HSBC Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
39,129
-8,274
| -17% | -$261K | ﹤0.01% | 1312 |
|
|
2025
Q1 | $1.54M | Sell |
47,403
-180,627
| -79% | -$5.87M | ﹤0.01% | 1211 |
|
|
2024
Q4 | $8.25M | Sell |
228,030
-22,334
| -9% | -$808K | ﹤0.01% | 822 |
|
|
2024
Q3 | $7.8M | Buy |
250,364
+236,354
| +1,687% | +$7.37M | ﹤0.01% | 824 |
|
|
2024
Q2 | $378K | Sell |
14,010
-173,394
| -93% | -$4.68M | ﹤0.01% | 1795 |
|
|
2024
Q1 | $6.38M | Buy |
187,404
+177,103
| +1,719% | +$6.03M | ﹤0.01% | 864 |
|
|
2023
Q4 | $297K | Sell |
10,301
-3,063
| -23% | -$88.2K | ﹤0.01% | 1837 |
|
|
2023
Q3 | $369K | Sell |
13,364
-13,553
| -50% | -$374K | ﹤0.01% | 1640 |
|
|
2023
Q2 | $803K | Buy |
26,917
+6,405
| +31% | +$191K | ﹤0.01% | 1420 |
|
|
2023
Q1 | $751K | Sell |
20,512
-6,818
| -25% | -$249K | ﹤0.01% | 1509 |
|
|
2022
Q4 | $973K | Buy |
27,330
+4,134
| +18% | +$147K | ﹤0.01% | 1584 |
|
|
2022
Q3 | $791K | Buy |
23,196
+5,344
| +30% | +$182K | ﹤0.01% | 1559 |
|
|
2022
Q2 | $512K | Buy |
17,852
+861
| +5% | +$24.7K | ﹤0.01% | 1932 |
|
|
2022
Q1 | $550K | Buy |
+16,991
| New | +$550K | ﹤0.01% | 2006 |
|
|
2021
Q3 | – | Sell |
-7,758
| Closed | -$241K | – | 2649 |
|
|
2021
Q2 | $241K | Buy |
+7,758
| New | +$241K | ﹤0.01% | 2230 |
|
|
2020
Q4 | – | Sell |
-15,111
| Closed | -$318K | – | 2633 |
|
|
2020
Q3 | $318K | Buy |
+15,111
| New | +$318K | ﹤0.01% | 1807 |
|
|
2018
Q2 | – | Sell |
-51,590
| Closed | -$2.36M | – | 2031 |
|
|
2018
Q1 | $2.36M | Buy |
+51,590
| New | +$2.36M | ﹤0.01% | 987 |
|
|
2017
Q1 | – | Sell |
-8,081
| Closed | -$204K | – | 2047 |
|
|
2016
Q4 | $204K | Buy |
+8,081
| New | +$204K | ﹤0.01% | 2083 |
|